1. Fleish H. Bisphosphonates in bone diseases. From the laboratory to the patient.
Third Edition. The Parthenon Publishing Group Inc.
2. Kanis JA. Drugs used for the treatment of Paget´s disease of bone.
Martin Dunnitz,1991:139-216.
3. O´Doherty DP, Bickerstaff DR, McCloskey EV, et al. Treatment of Paget´s disease of bone with aminohydroxybutylidene-1bisphosphonate. J Bone Min
Res 1990:5, 483-491.
4. Adami S, Salvagno, Guarrera G, et al. Treatment of Paget´s disease of bone with intravenous 4 amino-1hydroxybutylidene-1,1bisphosphonates. Calcif
Tissue Int 1986;39:226-229.
5. Siris E, Weinstein RS, Altman R, et al. Comparative study of alendronate versus etidronate for the treatment of Paget´s disease of bone. J Clin Endocrinol Metabol 1996;81 (3):961-967.
6. Reid IR, Nicholson GC, Weinstein RS, et al. Biochemical ad radiologic improvement in Paget´s disease of bone treated with alendronate. A randomized, placebo-controlled trial. Am J Med 1996;101:341-348.
7. Adami S, Mian M, Gatti P, et al. Effects of two oral doses of alendronate in the treatment of Paget´s disease of bone. Bone 1994;15:415-417.
8. Miller PD, Brown S
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.